These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

316 related articles for article (PubMed ID: 18519680)

  • 1. Functional and clinical evidence for NDRG2 as a candidate suppressor of liver cancer metastasis.
    Lee DC; Kang YK; Kim WH; Jang YJ; Kim DJ; Park IY; Sohn BH; Sohn HA; Lee HG; Lim JS; Kim JW; Song EY; Kim DM; Lee MN; Oh GT; Kim SJ; Park KC; Yoo HS; Choi JY; Yeom YI
    Cancer Res; 2008 Jun; 68(11):4210-20. PubMed ID: 18519680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of NF-kappaB activity by NDRG2 expression attenuates the invasive potential of highly malignant tumor cells.
    Kim A; Kim MJ; Yang Y; Kim JW; Yeom YI; Lim JS
    Carcinogenesis; 2009 Jun; 30(6):927-36. PubMed ID: 19336468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Expression of candidate tumor suppressor gene N-Myc downstream-regulated gene 2 in colon cancer].
    Chu DK; Zhang J; Shi H; Dong GL; Liu XP; Wang WZ
    Zhonghua Wei Chang Wai Ke Za Zhi; 2008 Jul; 11(4):354-7. PubMed ID: 18636358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of KiSS-1 gene and its role in invasion and metastasis of human hepatocellular carcinoma.
    Shengbing Z; Feng LJ; Bin W; Lingyun G; Aimin H
    Anat Rec (Hoboken); 2009 Aug; 292(8):1128-34. PubMed ID: 19645016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Integrative genomic analysis identifies NDRG2 as a candidate tumor suppressor gene frequently inactivated in clinically aggressive meningioma.
    Lusis EA; Watson MA; Chicoine MR; Lyman M; Roerig P; Reifenberger G; Gutmann DH; Perry A
    Cancer Res; 2005 Aug; 65(16):7121-6. PubMed ID: 16103061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NDRG2 is a candidate tumor-suppressor for oral squamous-cell carcinoma.
    Furuta H; Kondo Y; Nakahata S; Hamasaki M; Sakoda S; Morishita K
    Biochem Biophys Res Commun; 2010 Jan; 391(4):1785-91. PubMed ID: 20045673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced expression of N-Myc downstream-regulated gene 2 in human thyroid cancer.
    Zhao H; Zhang J; Lu J; He X; Chen C; Li X; Gong L; Bao G; Fu Q; Chen S; Lin W; Shi H; Ma J; Liu X; Ma Q; Yao L
    BMC Cancer; 2008 Oct; 8():303. PubMed ID: 18940011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Granulin-epithelin precursor overexpression promotes growth and invasion of hepatocellular carcinoma.
    Cheung ST; Wong SY; Leung KL; Chen X; So S; Ng IO; Fan ST
    Clin Cancer Res; 2004 Nov; 10(22):7629-36. PubMed ID: 15569995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of invasion and metastasis of hepatocellular carcinoma cells via targeting RhoC in vitro and in vivo.
    Wang W; Wu F; Fang F; Tao Y; Yang L
    Clin Cancer Res; 2008 Nov; 14(21):6804-12. PubMed ID: 18980974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Promoter methylation, mutation, and genomic deletion are involved in the decreased NDRG2 expression levels in several cancer cell lines.
    Liu N; Wang L; Liu X; Yang Q; Zhang J; Zhang W; Wu Y; Shen L; Zhang Y; Yang A; Han H; Zhang J; Yao L
    Biochem Biophys Res Commun; 2007 Jun; 358(1):164-9. PubMed ID: 17470364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of human NDRG2 by myeloid dendritic cells inhibits down-regulation of activated leukocyte cell adhesion molecule (ALCAM) and contributes to maintenance of T cell stimulatory activity.
    Choi SC; Kim KD; Kim JT; Kim JW; Lee HG; Kim JM; Jang YS; Yoon DY; Kim KI; Yang Y; Cho DH; Lim JS
    J Leukoc Biol; 2008 Jan; 83(1):89-98. PubMed ID: 17911180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NDRG2 gene expression in B16F10 melanoma cells restrains melanogenesis via inhibition of Mitf expression.
    Kim A; Yang Y; Lee MS; Yoo YD; Lee HG; Lim JS
    Pigment Cell Melanoma Res; 2008 Dec; 21(6):653-64. PubMed ID: 19067970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone morphogenetic protein 4 is induced in hepatocellular carcinoma by hypoxia and promotes tumour progression.
    Maegdefrau U; Amann T; Winklmeier A; Braig S; Schubert T; Weiss TS; Schardt K; Warnecke C; Hellerbrand C; Bosserhoff AK
    J Pathol; 2009 Aug; 218(4):520-9. PubMed ID: 19431154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of carboxypeptidase of glutamate like-B as a candidate suppressor in cell growth and metastasis in human hepatocellular carcinoma.
    Zhang P; Chan DW; Zhu Y; Li JJ; Ng IO; Wan D; Gu J
    Clin Cancer Res; 2006 Nov; 12(22):6617-25. PubMed ID: 17121880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Re-expression of transcription factor ATF5 in hepatocellular carcinoma induces G2-M arrest.
    Gho JW; Ip WK; Chan KY; Law PT; Lai PB; Wong N
    Cancer Res; 2008 Aug; 68(16):6743-51. PubMed ID: 18701499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intelectin 1 suppresses the growth, invasion and metastasis of neuroblastoma cells through up-regulation of N-myc downstream regulated gene 2.
    Li D; Mei H; Pu J; Xiang X; Zhao X; Qu H; Huang K; Zheng L; Tong Q
    Mol Cancer; 2015 Feb; 14():47. PubMed ID: 25889839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HTPAP gene on chromosome 8p is a candidate metastasis suppressor for human hepatocellular carcinoma.
    Wu X; Jia HL; Wang YF; Ren N; Ye QH; Sun HC; Wang L; Liu YK; Tang ZY; Qin LX
    Oncogene; 2006 Mar; 25(12):1832-40. PubMed ID: 16261160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A homeobox protein, prox1, is involved in the differentiation, proliferation, and prognosis in hepatocellular carcinoma.
    Shimoda M; Takahashi M; Yoshimoto T; Kono T; Ikai I; Kubo H
    Clin Cancer Res; 2006 Oct; 12(20 Pt 1):6005-11. PubMed ID: 17062673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-Myc downstream-regulated gene 4 (NDRG4): a candidate tumor suppressor gene and potential biomarker for colorectal cancer.
    Melotte V; Lentjes MH; van den Bosch SM; Hellebrekers DM; de Hoon JP; Wouters KA; Daenen KL; Partouns-Hendriks IE; Stessels F; Louwagie J; Smits KM; Weijenberg MP; Sanduleanu S; Khalid-de Bakker CA; Oort FA; Meijer GA; Jonkers DM; Herman JG; de Bruïne AP; van Engeland M
    J Natl Cancer Inst; 2009 Jul; 101(13):916-27. PubMed ID: 19535783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Expression of tumor metastasis-suppressor gene KiSS-1 and matrix metalloproteinase-9 in portal vein tumor thrombus of hepatocellular carcinoma].
    Hou YK; Wang Y; Cong WM; Wu MC
    Ai Zheng; 2007 Jun; 26(6):591-5. PubMed ID: 17562263
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.